研究業績（原著と症例報告のみ） 2017年

原著論文
1.
Cardiovascular Disease Prevalence and Insulin Resistance in the Kyushu-Okinawa Population Study and the Framingham Offspring Study.
Ikezaki H, Ai M, Schaefer EJ, Otokozawa S, Asztalos BF, Nakajima K, Zhou Y, Liu CT, Jacques PF, Cupples LA, Furusyo N.
J Clin Lipidol 11: 348-356, 2017
2.
Higher dietary cholesterol and omega-3 fatty acid intakes are associated with a lower successful rate of Helicobacter pylori eradication therapy in Japan.
Ikezaki H, Furusyo N, Jacques PF, Shimizu M, Murata M, Schaefer EJ, Urita Y, Hayashi J.
Am J Clin Nutr 106: 581-588, 2017.
3.
The relation between serum endostatin level and carotid atherosclerosis in healthy residents of Japan: Results from the Kyushu and Okinawa Population Study (KOPS).
Kato Y, Shimizu M, Furusyo N, Tanaka Y, Ueyama T, Yamasaki S, Murata M, Hayashi J.
J Atheroscler and Thromb 24: 1023-1030, 2017.
4.
Genetic variants of RAMP2 and CLR are associated with stroke.
Koyama T, Kuriyama N, Ozaki E, Matsui D, Watanabe I, Takeshita W, Iwai K, Watanabe Y, Nakatochi M, Shimanoe C, Tanaka K, Oze I, Ito H, Uemura H, Katsuura-Kamano S, Ibusuki R, Shimoshikiryo I, Naoyuki T, Aya K, Kawai S, Sasakabe T, Okada R, Hishida A, Naito M, Kuriki K, Endoh K, Furusyo N, Ikezaki H, Suzuki S, HosonoA, Mikami H, Nakamura Y, Kubo M, Wakai K.
J Atheroscler and Thromb 24: 1267-1281, 2017.
5.
Clinical and pathogenic features of SCCmec type II and IV methicillin-resistant Staphylococcus aureus in Japan.
Mitsumoto-Kaseida F, Murata M, Toyoda K, Morokuma Y, Kiyosuke M, Kang D, Furusyo N.
J Infect Chemother 23: 90-95, 2017.
6.
The Expression Level of Neutrophil CD64 Is a Useful Marker of Systemic Inflammation Associated with HIV Infection.
Mitsumoto-Kaseida F, Murata M, Ura K, Takayama K, Hiramine S, Shimizu M, Toyoda K, Ogawa E, Furusyo N.
AIDS Res Hum Retroviruses 33: 147-156, 2017.
7.
NS5A resistance-associated variants undermine the effectiveness of ledipasvir and sofosbuvir for cirrhotic patients infected with HCV genotype 1b.
Ogawa E, Furusyo N, Nomura H, Dohmen K, Higashi N, Takahashi K, Kawano A, Azuma K, Satoh T, Nakamuta M, Koyanagi T, Kato M, Shimoda S, Kajiwara E, Hayashi J; Kyushu University Liver Disease Study (KULDS) Group.
J Gastroenterol 52: 845-854, 2017.
8.
Impact of HCV kinetics on treatment outcome differs by the type of real-time HCV assay in NS3/4A protease inhibitor-based triple therapy.
Ogawa E, Furusyo N, Murata M, Hayashi T, Shimizu M, Mukae H, Toyoda K, Hotta T, Uchiumi T, Hayashi J.
Antiviral Res 126: 35-42, 2017.
9.
Comparison of the Abbott RealTime HCV and Roche COBAS Ampliprep/COBAS TaqMan HCV assays for the monitoring of sofosbuvir-based therapy.
Ogawa E, Furusyo N, Murata M, Shimizu M, Toyoda K, Hotta T, Uchiumi T, Hayashi J.
Antivir Ther 22: 61-70, 2017.
10.
高齢高血圧患者における推定塩分摂取量　総合診療医としての管理
林　純、小森彩佳、上山貴嗣、坂本篤彦、小川栄一、村田昌之、古庄憲浩
日本病院総合診療医学会雑誌 12: 33-35, 2017
11.
C型肝炎ウイルスに対する直接作用型抗ウイルス薬による血清脂質の変化
吉澤裕子、石田　茂、川尻雄大、南　晴奈、益口　賢、齊藤麻美、渡邊裕之、江頭伸昭、古庄憲浩、増田智先
九州薬学会会報 71: 45-50, 2017


症例報告
1.
Successful surgical intervention for rectal perforation due to polyarteritis nodosa: report of a case.
Yoshiya K, Imamura Y, Nakaji Y, Taniguchi D, Takeda R, Ando K, Nakashima Y, Shimizu M, Ohgaki K, Furusyo N, Matsumoto T, Saeki H, Oda Y, Oki E, Maehara Y.
Surg Case Rep 3: 43, 2017.
2.
A case of amebiasis with negative serologic markers that caused intra-abdominal abscess.
Tanaka R, Furusyo N, Takeda R, Yamasaki S, Kusaga A, Ogawa E, Murata M, Nakanishi R, Maehara Y.
J Infect Chemother 23:778-781, 2017.

＜研究分野・研究実績トップへ戻る

ページの先頭へ移動する